{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:10:03Z","timestamp":1794888603945,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02842-1","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T10:33:33Z","timestamp":1752143613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome stages 0\u20133: a prospective cohort study of 282,920 participants in the UK Biobank"],"prefix":"10.1186","volume":"24","author":[{"given":"Kun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingliu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"2842_CR1","unstructured":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u20132161."},{"issue":"20","key":"2842_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of Cardiovascular\u2013Kidney\u2013Metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"21","key":"2842_CR3","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular\u2013Kidney\u2013Metabolic syndrome stages in US adults, 2011\u20132020. JAMA. 2024;331(21):1858\u201360.","journal-title":"JAMA"},{"issue":"20","key":"2842_CR4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular\u2013Kidney\u2013Metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"key":"2842_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119: 154766.","journal-title":"Metabolism"},{"issue":"1","key":"2842_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"2842_CR7","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.metabol.2011.02.012","volume":"60","author":"IF Godsland","year":"2011","unstructured":"Godsland IF, Lecamwasam K, Johnston DG. A systematic evaluation of the insulin resistance syndrome as an independent risk factor for cardiovascular disease mortality and derivation of a clinical index. Metabolism. 2011;60(10):1442\u20138.","journal-title":"Metabolism"},{"issue":"2","key":"2842_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.numecd.2009.07.007","volume":"20","author":"M Matsuda","year":"2010","unstructured":"Matsuda M. Measuring and estimating insulin resistance in clinical and research settings. Nutr Metab Cardiovasc Dis. 2010;20(2):79\u201386.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"2842_CR9","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2842_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12933-024-02290-3","volume":"23","author":"X Xia","year":"2024","unstructured":"Xia X, Chen S, Tian X, Xu Q, Zhang Y, Zhang X, et al. Association of triglyceride-glucose index and its related parameters with atherosclerotic cardiovascular disease: evidence from a 15-year follow-up of Kailuan cohort. Cardiovasc Diabetol. 2024;23(1):208.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-023-01762-2","volume":"22","author":"B Che","year":"2023","unstructured":"Che B, Zhong C, Zhang R, Pu L, Zhao T, Zhang Y, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):34.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Min Y, Song G, Ye X, Liu L. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23(1):134.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-025-02576-0","volume":"24","author":"H Zhang","year":"2025","unstructured":"Zhang H, Tu Z, Liu S, Wang J, Shi J, Li X, et al. Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity. Cardiovasc Diabetol. 2025;24(1):33.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40001-024-01728-4","volume":"29","author":"H Rafiee","year":"2024","unstructured":"Rafiee H, Mohammadifard N, Nouri F, Alavi Tabatabaei G, Najafian J, Sadeghi M, et al. Association of triglyceride glucose index with cardiovascular events: insights from the Isfahan Cohort Study (ICS). Eur J Med Res. 2024;29(1):135.","journal-title":"Eur J Med Res"},{"issue":"1","key":"2842_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41387-024-00295-1","volume":"14","author":"H Liu","year":"2024","unstructured":"Liu H, Wang L, Wang H, Hao X, Du Z, Li C, et al. The association of triglyceride-glucose index with major adverse cardiovascular and cerebrovascular events after acute myocardial infarction: a meta-analysis of cohort studies. Nutr Diabetes. 2024;14(1):39.","journal-title":"Nutr Diabetes"},{"key":"2842_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132663","volume":"418","author":"A Avagimyan","year":"2025","unstructured":"Avagimyan A, Pogosova N, Fogacci F, Aghajanova E, Djndoyan Z, Patoulias D, et al. Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine. Int J Cardiol. 2025;418: 132663.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2842_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41387-025-00366-x","volume":"15","author":"E Sharifi-Zahabi","year":"2025","unstructured":"Sharifi-Zahabi E, Nasiri N, Hajizadeh-Sharafabad F, Sharifi M, Saber A. Triglyceride-glucose index and the risk of in-hospital and ICU all-cause mortality: a systematic review and meta-analysis of observational studies. Nutr Diabetes. 2025;15(1):8.","journal-title":"Nutr Diabetes"},{"issue":"1","key":"2842_CR19","doi-asserted-by":"publisher","first-page":"31352","DOI":"10.1038\/s41598-024-82881-y","volume":"14","author":"L Wu","year":"2024","unstructured":"Wu L, Huang Z. Elevated triglyceride glucose index is associated with advanced cardiovascular kidney metabolic syndrome. Sci Rep. 2024;14(1):31352.","journal-title":"Sci Rep"},{"issue":"1","key":"2842_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-024-02571-x","volume":"24","author":"Y Huang","year":"2025","unstructured":"Huang Y, Zhou Y, Xu Y, Wang X, Zhou Z, Wu K, et al. Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts. Cardiovasc Diabetol. 2025;24(1):11.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR22","doi-asserted-by":"publisher","first-page":"20593","DOI":"10.1038\/s41598-024-71579-w","volume":"14","author":"T Chen","year":"2024","unstructured":"Chen T, Wan H, Luo Y, Chen L. Association of triglyceride-glucose-body mass index with all-cause and cardiovascular mortality among individuals with chronic kidney disease. Sci Rep. 2024;14(1):20593.","journal-title":"Sci Rep"},{"issue":"1","key":"2842_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12933-023-01973-7","volume":"22","author":"A Khalaji","year":"2023","unstructured":"Khalaji A, Behnoush AH, Khanmohammadi S, Ghanbari Mardasi K, Sharifkashani S, Sahebkar A, et al. Triglyceride-glucose index and heart failure: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):244.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12944-024-02005-3","volume":"23","author":"AH Behnoush","year":"2024","unstructured":"Behnoush AH, Khalaji A, Ghondaghsaz E, Masrour M, Shokri Varniab Z, Khalaji S, et al. Triglyceride-glucose index and obstructive sleep apnea: a systematic review and meta-analysis. Lipids Health Dis. 2024;23(1):4.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2842_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41387-024-00341-y","volume":"14","author":"A Samavarchitehrani","year":"2024","unstructured":"Samavarchitehrani A, Cannavo A, Behnoush AH, Kazemi Abadi A, Shokri Varniab Z, Khalaji A. Investigating the association between the triglyceride-glucose index and peripheral artery disease: a systematic review and meta-analysis. Nutr Diabetes. 2024;14(1):80.","journal-title":"Nutr Diabetes"},{"issue":"1","key":"2842_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s40001-024-01716-8","volume":"29","author":"A Azarboo","year":"2024","unstructured":"Azarboo A, Behnoush AH, Vaziri Z, Daneshvar MS, Taghvaei A, Jalali A, et al. Assessing the association between triglyceride-glucose index and atrial fibrillation: a systematic review and meta-analysis. Eur J Med Res. 2024;29(1):118.","journal-title":"Eur J Med Res"},{"issue":"1","key":"2842_CR27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular\u2013Kidney\u2013Metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):292.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-025-02662-3","volume":"24","author":"J Hong","year":"2025","unstructured":"Hong J, Zhang R, Tang H, Wu S, Chen Y, Tan X. Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):98.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-025-02642-7","volume":"24","author":"P Zhang","year":"2025","unstructured":"Zhang P, Mo D, Zeng W, Dai H. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular\u2013kidney\u2013metabolic syndrome stage 0\u20133: a cohort study. Cardiovasc Diabetol. 2025;24(1):92.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2842_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3): e1001779.","journal-title":"PLoS Med"},{"issue":"2","key":"2842_CR31","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/ije\/dym276","volume":"37","author":"P Elliott","year":"2008","unstructured":"Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37(2):234\u201344.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2842_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12933-025-02689-6","volume":"24","author":"MY Tan","year":"2025","unstructured":"Tan MY, Zhang YJ, Zhu SX, Wu S, Zhang P, Gao M. The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0\u20133 of cardiovascular\u2013kidney\u2013metabolic syndrome: evidence from two cohort studies. Cardiovasc Diabetol. 2025;24(1):137.","journal-title":"Cardiovasc Diabetol"},{"key":"2842_CR33","doi-asserted-by":"crossref","unstructured":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439\u20132454","DOI":"10.1093\/eurheartj\/ehab369"},{"issue":"5","key":"2842_CR34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/jama.2019.9879","volume":"322","author":"I Lourida","year":"2019","unstructured":"Lourida I, Hannon E, Littlejohns TJ, Langa KM, Hypp\u00f6nen E, Kuzma E, et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA. 2019;322(5):430\u20137.","journal-title":"JAMA"},{"issue":"1","key":"2842_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank. Cardiovasc Diabetol. 2025;24(1):12.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2842_CR36","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ajcnut.2023.06.014","volume":"118","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Yang P, Jia Y, Wang Y, Shi M, Zhong C, et al. Plasma amino acid neurotransmitters and ischemic stroke prognosis: a Multicenter Prospective Study. Am J Clin Nutr. 2023;118(4):754\u201362.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2842_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB Sr, D\u2019Agostino Jr. RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157\u201372 (discussion 207-112).","journal-title":"Stat Med"},{"key":"2842_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.100996","volume":"22","author":"I Dakota","year":"2025","unstructured":"Dakota I, Huang W, Wijayanto MA, Nurhafizah A, Khairunnisa AR, Rachmayanti S, et al. Prognostic value of triglyceride-glucose index on predicting major adverse cardiovascular events in hypertensive patients: a systematic review and meta-analysis. Am J Prev Cardiol. 2025;22: 100996.","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"2842_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/dtom.2025.0002","volume":"1","author":"A Mousavi","year":"2025","unstructured":"Mousavi A, Radkhah H, Nasimi Shad A, Akhlaghipour I, Azarboo A, Forutan H, et al. Triglyceride-glucose index and major adverse cardiovascular events in diabetic and nondiabetic patients: a systematic review and meta-analysis. Diabetes Technol Obes Med. 2025;1(1):203\u201315.","journal-title":"Diabetes Technol Obes Med"},{"issue":"6","key":"2842_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/1933719110367829","volume":"17","author":"FR P\u00e9rez-L\u00f3pez","year":"2010","unstructured":"P\u00e9rez-L\u00f3pez FR, Larrad-Mur L, Kallen A, Chedraui P, Taylor HS. Gender differences in cardiovascular disease: hormonal and biochemical influences. Reprod Sci. 2010;17(6):511\u201331.","journal-title":"Reprod Sci"},{"issue":"1","key":"2842_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12933-021-01238-1","volume":"20","author":"A Wang","year":"2021","unstructured":"Wang A, Wang G, Liu Q, Zuo Y, Chen S, Tao B, et al. Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: an 11-year follow-up. Cardiovasc Diabetol. 2021;20(1):46.","journal-title":"Cardiovasc Diabetol"},{"key":"2842_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.583473","volume":"7","author":"S Si","year":"2020","unstructured":"Si S, Li J, Li Y, Li W, Chen X, Yuan T, et al. Causal effect of the triglyceride-glucose index and the joint exposure of higher glucose and triglyceride with extensive cardio-cerebrovascular metabolic outcomes in the UK Biobank: a Mendelian Randomization Study. Front Cardiovasc Med. 2020;7: 583473.","journal-title":"Front Cardiovasc Med"},{"issue":"21","key":"2842_CR43","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984\u20131010.","journal-title":"Circulation"},{"issue":"16","key":"2842_CR44","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019;139(16):e840\u201378.","journal-title":"Circulation"},{"issue":"9","key":"2842_CR45","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/ijms20092358","volume":"20","author":"M Longo","year":"2019","unstructured":"Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20(9):2358.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2842_CR46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):188.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-025-02589-9","volume":"24","author":"G Zheng","year":"2025","unstructured":"Zheng G, Jin J, Wang F, Zheng Q, Shao J, Yao J, et al. Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):22.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2842_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12933-025-02742-4","volume":"24","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Cao Z, Teng J, Lu Q, Huang P, Zhou J. Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular\u2013Kidney\u2013Metabolic syndrome. Cardiovasc Diabetol. 2025;24(1):183.","journal-title":"Cardiovasc Diabetol"},{"key":"2842_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112189","volume":"224","author":"M Di Marco","year":"2025","unstructured":"Di Marco M, Scilletta S, Miano N, Capuccio S, Musmeci M, Di Mauro S, et al. Triglycerides to high density lipoprotein cholesterol ratio (TG\/HDL), but not triglycerides and glucose product (TyG) index, is associated with arterial stiffness in prediabetes. Diabetes Res Clin Pract. 2025;224: 112189.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"2842_CR50","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.numecd.2023.12.001","volume":"34","author":"S Darroudi","year":"2024","unstructured":"Darroudi S, Mahdavizadeh V, Mirzaei AH, Esparham A, Ahmadyar S, Esmaily H, et al. Triglyceride glucose index and triglyceride HDL ratio as predictors of coronary artery stenosis in diabetic and non-diabetic patients. Nutr Metab Cardiovasc Dis. 2024;34(7):1692\u20135.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"2842_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.102344","volume":"49","author":"SA Sebastian","year":"2024","unstructured":"Sebastian SA, Padda I, Johal G. Cardiovascular\u2013Kidney\u2013Metabolic (CKM) syndrome: a state-of-the-art review. Curr Probl Cardiol. 2024;49(2): 102344.","journal-title":"Curr Probl Cardiol"},{"key":"2842_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.yjmcc.2013.08.005","volume":"64","author":"TM Fullmer","year":"2013","unstructured":"Fullmer TM, Pei S, Zhu Y, Sloan C, Manzanares R, Henrie B, et al. Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms. J Mol Cell Cardiol. 2013;64:20\u20139.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"2842_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21\u20138.","journal-title":"Diabetologia"},{"issue":"1","key":"2842_CR54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12933-024-02354-4","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang F, Tang J, Shen L, He J, Chen Y. Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018. Cardiovasc Diabetol. 2024;23(1):262.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"2842_CR55","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41580-018-0044-8","volume":"19","author":"Q Yang","year":"2018","unstructured":"Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol. 2018;19(10):654\u201372.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2842_CR56","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"2842_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595\u2013602.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2842_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12933-023-01864-x","volume":"22","author":"W Cai","year":"2023","unstructured":"Cai W, Xu J, Wu X, Chen Z, Zeng L, Song X, et al. Association between triglyceride-glucose index and all-cause mortality in critically ill patients with ischemic stroke: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22(1):138.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"2842_CR59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11906-012-0292-5","volume":"14","author":"E Rojas","year":"2012","unstructured":"Rojas E, Velasco M, Berm\u00fadez V, Israili Z, Bolli P. Targeting hypertension in patients with cardiorenal metabolic syndrome. Curr Hypertens Rep. 2012;14(5):397\u2013402.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"2842_CR60","doi-asserted-by":"publisher","first-page":"300060523116454","DOI":"10.1177\/03000605231164548","volume":"51","author":"CE Kosmas","year":"2023","unstructured":"Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E. Insulin resistance and cardiovascular disease. J Int Med Res. 2023;51(3):3000605231164548.","journal-title":"J Int Med Res"},{"issue":"1","key":"2842_CR61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4093\/dmj.2023.0110","volume":"48","author":"Y Fan","year":"2024","unstructured":"Fan Y, Yan Z, Li T, Li A, Fan X, Qi Z, et al. Primordial drivers of diabetes heart disease: comprehensive insights into insulin resistance. Diabetes Metab J. 2024;48(1):19\u201336.","journal-title":"Diabetes Metab J"},{"issue":"1\u20133","key":"2842_CR62","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejphar.2013.07.024","volume":"719","author":"O Thibault","year":"2013","unstructured":"Thibault O, Anderson KL, DeMoll C, Brewer LD, Landfield PW, Porter NM. Hippocampal calcium dysregulation at the nexus of diabetes and brain aging. Eur J Pharmacol. 2013;719(1\u20133):34\u201343.","journal-title":"Eur J Pharmacol"},{"key":"2842_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m131","volume":"368","author":"GD Batty","year":"2020","unstructured":"Batty GD, Gale CR, Kivim\u00e4ki M, Deary IJ, Bell S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ. 2020;368: m131.","journal-title":"BMJ"},{"issue":"7","key":"2842_CR64","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41562-023-01579-9","volume":"7","author":"T Schoeler","year":"2023","unstructured":"Schoeler T, Speed D, Porcu E, Pirastu N, Pingault JB, Kutalik Z. Participation bias in the UK Biobank distorts genetic associations and downstream analyses. Nat Hum Behav. 2023;7(7):1216\u201327.","journal-title":"Nat Hum Behav"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02842-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02842-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02842-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:53:40Z","timestamp":1757231620000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02842-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2842"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02842-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"17 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Northwest Multi-center Research Ethics Committee (MREC reference: 21\/NW\/0157) provided ethical approval for the UK Biobank project. All participants gave informed consent before being recruited.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"277"}}